BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li CL, Nie H, Wang M, Su LP, Li JF, Yu YY, Yan M, Qu QL, Zhu ZG, Liu BY. microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncol Rep 2012;27:1960-6. [PMID: 22426647 DOI: 10.3892/or.2012.1719] [Cited by in Crossref: 15] [Cited by in F6Publishing: 50] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Zhang X, Yang K, Shao Y, Gu R, Liu X, Liu H, Liu Y, Zhou Y. Macrophage-derived apoptotic vesicles regulate fate commitment of mesenchymal stem cells via miR155. Stem Cell Res Ther 2022;13:323. [PMID: 35842708 DOI: 10.1186/s13287-022-03004-w] [Reference Citation Analysis]
2 Mahbobi R, Fallah F, Behmanesh A, Yadegar A, Hakemi-Vala M, Ehsanzadeh SJ, Shams R. Helicobacter pylori Infection Mediates Inflammation and Tumorigenesis-Associated Genes Through miR-155-5p: An Integrative Omics and Bioinformatics-Based Investigation. Curr Microbiol 2022;79:192. [PMID: 35551487 DOI: 10.1007/s00284-022-02880-y] [Reference Citation Analysis]
3 Szczepanek J, Skorupa M, Tretyn A. MicroRNA as a Potential Therapeutic Molecule in Cancer. Cells 2022;11:1008. [PMID: 35326459 DOI: 10.3390/cells11061008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Svoronos AA, Campbell SG, Engelman DM. MicroRNA function can be reversed by altering target gene expression levels. iScience 2021;24:103208. [PMID: 34755085 DOI: 10.1016/j.isci.2021.103208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Bure IV, Nemtsova MV. Methylation and Noncoding RNAs in Gastric Cancer: Everything Is Connected. Int J Mol Sci 2021;22:5683. [PMID: 34073603 DOI: 10.3390/ijms22115683] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
6 Wahiduzzaman M, Ota A, Hosokawa Y. Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide. Curr Cancer Drug Targets 2020;20:115-29. [PMID: 31736446 DOI: 10.2174/1568009619666191021122006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shan C, Chen X, Cai H, Hao X, Li J, Zhang Y, Gao J, Zhou Z, Li X, Liu C, Li P, Wang K. The Emerging Roles of Autophagy-Related MicroRNAs in Cancer. Int J Biol Sci 2021;17:134-50. [PMID: 33390839 DOI: 10.7150/ijbs.50773] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kirave P, Gondaliya P, Kulkarni B, Rawal R, Garg R, Jain A, Kalia K. Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition. Oncotarget 2020;11:1157-71. [PMID: 32284792 DOI: 10.18632/oncotarget.27531] [Cited by in Crossref: 21] [Cited by in F6Publishing: 30] [Article Influence: 10.5] [Reference Citation Analysis]
9 Park JH, Seo JH, Jeon HY, Seo SM, Lee HK, Park JI, Kim JY, Choi YK. Lentivirus-Mediated VEGF Knockdown Suppresses Gastric Cancer Cell Proliferation and Tumor Growth in vitro and in vivo. Onco Targets Ther 2020;13:1331-41. [PMID: 32104000 DOI: 10.2147/OTT.S234344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol 2020;11:90. [PMID: 32117120 DOI: 10.3389/fmicb.2020.00090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
11 Condrat CE, Thompson DC, Barbu MG, Bugnar OL, Boboc A, Cretoiu D, Suciu N, Cretoiu SM, Voinea SC. miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells 2020;9:E276. [PMID: 31979244 DOI: 10.3390/cells9020276] [Cited by in Crossref: 132] [Cited by in F6Publishing: 259] [Article Influence: 66.0] [Reference Citation Analysis]
12 Zou W, Li X, Li C, Liu D, Lv Y, Yang Y, Ye N, Guo D, He S. Analysis of the relationship between MIR155HG variants and gastric Cancer susceptibility. BMC Gastroenterol 2020;20:17. [PMID: 31959117 DOI: 10.1186/s12876-020-1169-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Ekiz HA, Huffaker TB, Grossmann AH, Stephens WZ, Williams MA, Round JL, O'Connell RM. MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers. JCI Insight 2019;4:126543. [PMID: 30721153 DOI: 10.1172/jci.insight.126543] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
14 Amodio N, Gallo Cantafio ME, Botta C, Agosti V, Federico C, Caracciolo D, Ronchetti D, Rossi M, Driessen C, Neri A, Tagliaferri P, Tassone P. Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers (Basel) 2019;11:E236. [PMID: 30781685 DOI: 10.3390/cancers11020236] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
15 Petrovic N, Ergün S, Isenovic ER. Levels of MicroRNA Heterogeneity in Cancer Biology. Mol Diagn Ther 2017;21:511-23. [PMID: 28620889 DOI: 10.1007/s40291-017-0285-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
16 Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA. Using microRNA Networks to Understand Cancer. Int J Mol Sci 2018;19:E1871. [PMID: 29949872 DOI: 10.3390/ijms19071871] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 10.5] [Reference Citation Analysis]
17 Lin J, Chen Y, Liu L, Shen A, Zheng W. MicroRNA-155-5p suppresses the migration and invasion of lung adenocarcinoma A549 cells by targeting Smad2. Oncol Lett 2018;16:2444-52. [PMID: 30013636 DOI: 10.3892/ol.2018.8889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
18 Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers. Pathol Oncol Res. 2018;24:757-770. [PMID: 29552712 DOI: 10.1007/s12253-018-0410-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
19 Arunkumar G, Murugan AK, Prasanna Srinivasa Rao H, Subbiah S, Rajaraman R, Munirajan AK. Long non-coding RNA CCAT1 is overexpressed in oral squamous cell carcinomas and predicts poor prognosis. Biomed Rep 2017;6:455-62. [PMID: 28413645 DOI: 10.3892/br.2017.876] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 7.2] [Reference Citation Analysis]
20 Oliveto S, Mancino M, Manfrini N, Biffo S. Role of microRNAs in translation regulation and cancer. World J Biol Chem 2017; 8(1): 45-56 [PMID: 28289518 DOI: 10.4331/wjbc.v8.i1.45] [Cited by in CrossRef: 224] [Cited by in F6Publishing: 210] [Article Influence: 44.8] [Reference Citation Analysis]
21 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
22 Bi C, Chung TH, Huang G, Zhou J, Yan J, Ahmann GJ, Fonseca R, Chng WJ. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. Oncotarget 2015;6:26508-18. [PMID: 26164366 DOI: 10.18632/oncotarget.4769] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
23 Szűcs D, Béres NJ, Rokonay R, Boros K, Borka K, Kiss Z, Arató A, Szabó AJ, Vannay &, Sziksz E, Bereczki C, Veres G. Increased duodenal expression of miR-146a and -155 in pediatric Crohn’s disease. World J Gastroenterol 2016; 22(26): 6027-6035 [PMID: 27468194 DOI: 10.3748/wjg.v22.i26.6027] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
24 Svoronos AA, Engelman DM, Slack FJ. OncomiR or Tumor Suppressor? Cancer Res. 2016;76:3666-3670. [PMID: 27325641 DOI: 10.1158/0008-5472.can-16-0359] [Cited by in Crossref: 329] [Cited by in F6Publishing: 401] [Article Influence: 54.8] [Reference Citation Analysis]
25 Wan J, Xia L, Xu W, Lu N. Expression and Function of miR-155 in Diseases of the Gastrointestinal Tract.Int J Mol Sci. 2016;17. [PMID: 27187359 DOI: 10.3390/ijms17050709] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
26 Peng Y, Dong W, Lin TX, Zhong GZ, Liao B, Wang B, Gu P, Huang L, Xie Y, Lu FD, Chen X, Xie WB, He W, Wu SX, Huang J. MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1. Oncotarget 2015;6:16043-58. [PMID: 25965824 DOI: 10.18632/oncotarget.3755] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
27 Ma Z, Ma Y, Xia Q, Li Y, Li R, Chang W, Chen J, Leng Z, Tao K. MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1. J Cancer Res Clin Oncol. 2016;142:1201-1212. [PMID: 26955820 DOI: 10.1007/s00432-016-2139-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
28 Osaka E, Kelly AD, Spentzos D, Choy E, Yang X, Shen JK, Yang P, Mankin HJ, Hornicek FJ, Duan Z. MicroRNA-155 expression is independently predictive of outcome in chordoma. Oncotarget 2015;6:9125-39. [PMID: 25823817 DOI: 10.18632/oncotarget.3273] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
29 Chen W, Huang L, Hao C, Zeng W, Luo X, Li X, Zhou L, Jiang S, Chen Z, He Y. MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells. Tumour Biol 2016;37:9289-99. [PMID: 26779627 DOI: 10.1007/s13277-016-4804-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
30 Li Y, Jiang F, Chen L, Yang Y, Cao S, Ye Y, Wang X, Mu J, Li Z, Li L. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo. FEBS Open Bio 2015;5:466-75. [PMID: 26106521 DOI: 10.1016/j.fob.2015.05.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
31 Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015;22:291-301. [DOI: 10.1038/cgt.2015.19] [Cited by in Crossref: 62] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
32 Li Z, Yu X, Shen J, Chan MT, Wu WK. MicroRNA in intervertebral disc degeneration. Cell Prolif 2015;48:278-83. [PMID: 25736871 DOI: 10.1111/cpr.12180] [Cited by in Crossref: 102] [Cited by in F6Publishing: 114] [Article Influence: 14.6] [Reference Citation Analysis]
33 Tang G, Shen X, Lv K, Wu Y, Bi J, Shen Q. Different normalization strategies might cause inconsistent variation in circulating microRNAs in patients with hepatocellular carcinoma. Med Sci Monit. 2015;21:617-624. [PMID: 25719241 DOI: 10.12659/msm.891028] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
34 Wan X, Ding X, Chen S, Song H, Jiang H, Fang Y, Li P, Guo J. The functional sites of miRNAs and lncRNAs in gastric carcinogenesis. Tumour Biol. 2015;36:521-532. [PMID: 25636450 DOI: 10.1007/s13277-015-3136-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
35 Xu N, Li Z, Yu Z, Yan F, Liu Y, Lu X, Yang W. MicroRNA-33b suppresses migration and invasion by targeting c-Myc in osteosarcoma cells. PLoS One 2014;9:e115300. [PMID: 25546234 DOI: 10.1371/journal.pone.0115300] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
36 Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen J, Yang X. Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer. Cancer Sci. 2014;105:1541-1549. [PMID: 25283513 DOI: 10.1111/cas.12548] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
37 Alečković M, Kang Y. Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta 2015;1855:24-42. [PMID: 25450578 DOI: 10.1016/j.bbcan.2014.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 54] [Article Influence: 2.6] [Reference Citation Analysis]
38 Pinheiro DDR, Ferreira WAS, Barros MBL, Araújo MD, Rodrigues-Antunes S, Borges BDN. Perspectives on new biomarkers in gastric cancer: Diagnostic and prognostic applications. World J Gastroenterol 2014; 20(33): 11574-11585 [PMID: 25206265 DOI: 10.3748/wjg.v20.i33.11574] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
39 Li DJ, Zhang GY, Jie ZG, Li ZR. MicroRNAs related to invasiveness and metastasis of gastric cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(22): 3219-3224 [DOI: 10.11569/wcjd.v22.i22.3219] [Reference Citation Analysis]
40 Kang C, Song JJ, Lee J, Kim MY. Epigenetics: An emerging player in gastric cancer. World J Gastroenterol 2014; 20(21): 6433-6447 [PMID: 24914365 DOI: 10.3748/wjg.v20.i21.6433] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
41 Li PF, Chen SC, Xia T, Jiang XM, Shao YF, Xiao BX, Guo JM. Non-coding RNAs and gastric cancer. World J Gastroenterol 2014; 20(18): 5411-5419 [PMID: 24833871 DOI: 10.3748/wjg.v20.i18.5411] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 91] [Article Influence: 11.1] [Reference Citation Analysis]
42 Li L, Hu X, Yang Z, Jia Z, Fang M, Zhang L, Zhou Y. Establishing reliable miRNA-cancer association network based on text-mining method. Comput Math Methods Med 2014;2014:746979. [PMID: 24895499 DOI: 10.1155/2014/746979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
43 Sun J, Shi H, Lai N, Liao K, Zhang S, Lu X. Overexpression of microRNA-155 predicts poor prognosis in glioma patients. Med Oncol 2014;31:911. [PMID: 24623016 DOI: 10.1007/s12032-014-0911-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
44 Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu B, Yan M, Yu Y, Liu B, Zhu Z. MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer. 2014;14:34. [PMID: 24443799 DOI: 10.1186/1471-2407-14-34] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
45 Ma J, Hong L, Chen Z, Nie Y, Fan D. Epigenetic regulation of microRNAs in gastric cancer. Dig Dis Sci. 2014;59:716-723. [PMID: 24248419 DOI: 10.1007/s10620-013-2939-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
46 Li P, Chen X, Su L, Li C, Zhi Q, Yu B, Sheng H, Wang J, Feng R, Cai Q, Li J, Yu Y, Yan M, Liu B, Zhu Z. Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One 2013;8:e66782. [PMID: 23826132 DOI: 10.1371/journal.pone.0066782] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
47 Onyeagucha BC, Mercado-Pimentel ME, Hutchison J, Flemington EK, Nelson MA. S100P/RAGE signaling regulates microRNA-155 expression via AP-1 activation in colon cancer. Exp Cell Res 2013;319:2081-90. [PMID: 23693020 DOI: 10.1016/j.yexcr.2013.05.009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
48 Yu HW, Sze DM, Cho WC. MicroRNAs Involved in Anti-Tumour Immunity. Int J Mol Sci. 2013;14:5587-5607. [PMID: 23478435 DOI: 10.3390/ijms14035587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
49 Jeansonne D, Pacifici M, Lassak A, Reiss K, Russo G, Zabaleta J, Peruzzi F. Differential Effects of MicroRNAs on Glioblastoma Growth and Migration. Genes (Basel) 2013;4:46-64. [PMID: 24705102 DOI: 10.3390/genes4010046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
50 Nam S, Long X, Kwon C, Kim S, Nephew KP. An integrative analysis of cellular contexts, miRNAs and mRNAs reveals network clusters associated with antiestrogen-resistant breast cancer cells. BMC Genomics 2012;13:732. [PMID: 23270413 DOI: 10.1186/1471-2164-13-732] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]